[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 59 of about 59
1. Kitcher E, Yarney J, Gyasi R, Cheyuo C: Laryngeal cancer at the korle bu teaching hospital accra ghana. Ghana Med J; 2006 Jun;40(2):45-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laryngeal cancer at the korle bu teaching hospital accra ghana.
  • SUMMARY INTRODUCTION: Laryngeal cancer is the commonest Head and Neck cancer seen at the Ear Nose and Throat (ENT) Unit Korle-Bu Teaching Hospital.
  • The aim of this study was to determine the number of cases of laryngeal cancer seen at the Korle Bu Teaching Hospital, establish epidemiological parameters of the disease and to outline preventive measures.
  • METHOD: One hundred and fifteen (115) patients who were managed for laryngeal cancer from 1(st) January 1998 to 31(st) December 2003 were studied retrospectively with respect to age, sex, duration of symptoms at presentation, risk factors, symptoms complex, histopathology, stage of tumor, details of treatment offered and follow up.
  • CONCLUSIONS: We conclude that significant number of patients with laryngeal cancer presented with locally advanced disease and dysphonia was the commonest symptom.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1975 Jul;85(7):1190-6 [1152568.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):21-8 [1993628.001]
  • [Cites] Am J Surg. 1991 Oct;162(4):337-40 [1951884.001]
  • (PMID = 17299565.001).
  • [ISSN] 0016-9560
  • [Journal-full-title] Ghana medical journal
  • [ISO-abbreviation] Ghana Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ghana
  • [Other-IDs] NLM/ PMC1790844
  •  go-up   go-down


2. Chung C, Mesa J, Randolph MA, Yaremchuk M, Burdick JA: Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks. J Biomed Mater Res A; 2006 Jun 1;77(3):518-25
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks.
  • The objective of this study was to determine how changes in the network structure and properties of hyaluronic acid (HA) hydrogels, due to variations in the macromer molecular weight (50-1,100 kDa) and macromer concentration (2-20 wt %), affect neocartilage formation by encapsulated auricular chondrocytes.
  • To investigate tissue formation, swine auricular chondrocytes were photoencapsulated in the various networks, implanted subcutaneously in the dorsum of nude mice, and explanted after 6 and 12 weeks for biochemical and histological analysis.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biomacromolecules. 2005 Jan-Feb;6(1):386-91 [15638543.001]
  • [Cites] Wound Repair Regen. 1999 Mar-Apr;7(2):79-89 [10231509.001]
  • [Cites] J Biomed Mater Res. 1996 Summer;33(2):57-63 [8736023.001]
  • [Cites] Biomaterials. 2000 Apr;21(8):795-801 [10721748.001]
  • [Cites] J Biomed Mater Res. 2000 Aug;51(2):164-71 [10825215.001]
  • [Cites] J Biomater Sci Polym Ed. 2000;11(5):439-57 [10896041.001]
  • [Cites] J Biomed Mater Res. 2001 Jan;54(1):115-21 [11077410.001]
  • [Cites] Biomaterials. 2001 Sep;22(17):2417-24 [11511039.001]
  • [Cites] Annu Rev Biomed Eng. 1999;1:19-46 [11701481.001]
  • [Cites] Clin Orthop Relat Res. 2005 Jun;(435):96-105 [15930926.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3104-7 [10077644.001]
  • [Cites] Cancer Lett. 1998 Sep 11;131(1):3-11 [9839614.001]
  • [Cites] Plast Reconstr Surg. 1998 May;101(6):1580-5 [9583489.001]
  • [Cites] Ann Plast Surg. 1998 Apr;40(4):413-20; discussion 420-1 [9555998.001]
  • [Cites] Anal Biochem. 1997 Jul 1;249(2):228-38 [9212875.001]
  • [Cites] Plast Reconstr Surg. 1995 Nov;96(6):1390-8; discussion 1399-400 [7480239.001]
  • [Cites] Biotechnology (N Y). 1994 Jul;12(7):689-93 [7764913.001]
  • [Cites] J Orthop Res. 2001 Nov;19(6):1113-21 [11781013.001]
  • [Cites] Tissue Eng. 2002 Oct;8(5):817-26 [12459060.001]
  • [Cites] Clin Orthop Relat Res. 1984 Jun;(186):231-9 [6723151.001]
  • [Cites] Anal Biochem. 1988 Oct;174(1):168-76 [2464289.001]
  • [Cites] Connect Tissue Res. 1982;9(4):247-8 [6215207.001]
  • [Cites] Biochem J. 1977 Feb 1;161(2):303-12 [322656.001]
  • [Cites] Clin Chim Acta. 1967 Nov;18(2):267-73 [4864804.001]
  • [Cites] Biorheology. 2004;41(3-4):411-21 [15299273.001]
  • [Cites] Biotechnol Bioeng. 2004 Jun 30;86(7):747-55 [15162450.001]
  • [Cites] Ann Biomed Eng. 2004 Mar;32(3):391-7 [15095813.001]
  • [Cites] J Biomed Mater Res A. 2003 Aug 1;66(2):317-29 [12889002.001]
  • (PMID = 16482551.001).
  • [ISSN] 1549-3296
  • [Journal-full-title] Journal of biomedical materials research. Part A
  • [ISO-abbreviation] J Biomed Mater Res A
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / DE015761-02; United States / NIDCR NIH HHS / DE / K22 DE015761; United States / NIDCR NIH HHS / DE / K22 DE-015761; United States / NIDCR NIH HHS / DE / K22 DE015761-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Hydrogels; 9004-61-9 / Hyaluronic Acid
  • [Other-IDs] NLM/ NIHMS103722; NLM/ PMC2678571
  •  go-up   go-down


3. Kim P: Prophylactic Z-plasty - correcting helical rim deformity from wedge excision. Aust Fam Physician; 2010 Sep;39(9):649-50
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Wedge excision is a popular and well documented surgical method for treating a wide range of skin lesions and cancers of the ear in the general practice setting.
  • [MeSH-major] Ear, External / surgery. Skin Neoplasms / surgery. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20877769.001).
  • [ISSN] 0300-8495
  • [Journal-full-title] Australian family physician
  • [ISO-abbreviation] Aust Fam Physician
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


Advertisement
4. Chung C, Erickson IE, Mauck RL, Burdick JA: Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Tissue Eng Part A; 2008 Jul;14(7):1121-31
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels.
  • Chondrocytes isolated from a variety of sources, including auricular (AU) and articular (AR) cartilage, can differ in cell behavior, growth, and extracellular matrix (ECM) production, which can impact neocartilage properties in tissue engineering approaches.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Histochem Cytochem. 2002 Aug;50(8):1049-58 [12133908.001]
  • [Cites] J Orthop Res. 2001 Nov;19(6):1113-21 [11781013.001]
  • [Cites] Tissue Eng. 2002 Oct;8(5):817-26 [12459060.001]
  • [Cites] Plast Reconstr Surg. 2004 Apr 15;113(5):1361-71 [15060348.001]
  • [Cites] Ann Biomed Eng. 2004 Mar;32(3):407-17 [15095815.001]
  • [Cites] Tissue Eng. 2004 May-Jun;10(5-6):762-70 [15265293.001]
  • [Cites] Biorheology. 2004;41(3-4):411-21 [15299273.001]
  • [Cites] Biomaterials. 2005 Apr;26(11):1211-8 [15475050.001]
  • [Cites] Clin Chim Acta. 1967 Nov;18(2):267-73 [4864804.001]
  • [Cites] Biochim Biophys Acta. 1970 Jul 21;215(1):70-7 [4250263.001]
  • [Cites] Biochem J. 1977 Feb 1;161(2):303-12 [322656.001]
  • [Cites] J Bone Joint Surg Am. 1982 Jan;64(1):88-94 [7054208.001]
  • [Cites] Connect Tissue Res. 1982;9(4):247-8 [6215207.001]
  • [Cites] Anal Biochem. 1997 Jul 1;249(2):228-38 [9212875.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jul 9;236(1):10-5 [9223416.001]
  • [Cites] J Biol Chem. 1998 Aug 28;273(35):22466-70 [9712871.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Oct 29;251(3):824-9 [9790994.001]
  • [Cites] Cancer Lett. 1998 Sep 11;131(1):3-11 [9839614.001]
  • [Cites] Wound Repair Regen. 1999 Mar-Apr;7(2):79-89 [10231509.001]
  • [Cites] Tissue Eng. 2004 Sep-Oct;10(9-10):1308-15 [15588391.001]
  • [Cites] Biomacromolecules. 2005 Jan-Feb;6(1):386-91 [15638543.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 Sep;133(3):417-22 [16143193.001]
  • [Cites] J Biomed Mater Res A. 2006 Jun 1;77(3):518-25 [16482551.001]
  • [Cites] Tissue Eng. 2006 Apr;12(4):691-703 [16674284.001]
  • [Cites] Osteoarthritis Cartilage. 2006 Sep;14(9):849-58 [16600643.001]
  • [Cites] Matrix Biol. 2006 Aug;25(6):323-31 [16697175.001]
  • [Cites] Tissue Eng. 2006 Sep;12(9):2665-73 [16995800.001]
  • [Cites] Biomech Model Mechanobiol. 2007 Jan;6(1-2):113-25 [16691412.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Jan 14;60(2):243-62 [17976858.001]
  • [Cites] J Biomater Sci Polym Ed. 2000;11(5):439-57 [10896041.001]
  • [Cites] J Biomech Eng. 2000 Jun;122(3):252-60 [10923293.001]
  • [Cites] J Biomed Mater Res. 2001 Jan;54(1):115-21 [11077410.001]
  • [Cites] Plast Reconstr Surg. 2001 Aug;108(2):392-402 [11496181.001]
  • [Cites] Biomacromolecules. 2002 Nov-Dec;3(6):1304-11 [12425669.001]
  • (PMID = 18407752.001).
  • [ISSN] 1937-3341
  • [Journal-full-title] Tissue engineering. Part A
  • [ISO-abbreviation] Tissue Eng Part A
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / K22DE015761; United States / NIAMS NIH HHS / AR / R03 AR053668; United States / NIDCR NIH HHS / DE / DE015761-05; United States / NIDCR NIH HHS / DE / K22 DE015761-05; United States / NIAMS NIH HHS / AR / R03AR053668; United States / NIDCR NIH HHS / DE / K22 DE015761
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Extracellular Matrix Proteins; 0 / Hydrogels; 9004-61-9 / Hyaluronic Acid
  • [Other-IDs] NLM/ NIHMS98281; NLM/ PMC2667224
  •  go-up   go-down


5. Harding C, Harris A, Chadwick D: Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int; 2009 Jan;103(2):186-90
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer.
  • OBJECTIVES: To evaluate the role of auricular acupuncture (AA) in men receiving luteinizing-hormone releasing hormone (LHRH) analogues for carcinoma of the prostate, as vasomotor symptoms can affect the quality of life in such men, and similar symptoms in postmenopausal women have been successfully treated with AA.
  • PATIENTS AND METHODS: In all, 60 consecutive patients with prostate cancer and on LHRH agonist treatment (median age 74 years, range 58-83) consented to weekly AA for 10 weeks.
  • [MeSH-major] Acupuncture, Ear / methods. Androgen Antagonists / adverse effects. Gonadotropin-Releasing Hormone / agonists. Hot Flashes / therapy. Prostatic Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18710455.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Androgen Antagonists; 33515-09-2 / Gonadotropin-Releasing Hormone
  •  go-up   go-down


6. Elbayoumi TA, Torchilin VP: Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice. Int J Pharm; 2008 Jun 5;357(1-2):272-9
Hazardous Substances Data Bank. DOXORUBICIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.
  • A mucocutaneous reaction in mice associated with Doxil treatment was identified as auricular erythema (AE).
  • This problem is of general significance, since cutaneous reactions often lead to alterations of Doxil dosing regimen in patients and might subsequently compromise the therapeutic outcome of cancer treatment.
  • Tumor-bearing mice were used to study the biodistribution and skin-tissue accumulation effects of the tumor-targeted Doxil (the clinically used anti-cancer formulation) coupled with the anti-cancer monoclonal 2C5 antibody (mAb 2C5) as well as AE caused by Doxil application.
  • Thus, targeting of Doxil with the anti-cancer mAb 2C5 not only can increase the tumor-specific accumulation of the drug, but also diminishes the cutaneous side effect of the original Doxil therapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Drugs. 2006 Jun;17(5):587-95 [16702817.001]
  • [Cites] Oncology. 2005;69(4):348-53 [16293974.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205 [16763815.001]
  • [Cites] J Liposome Res. 2007;17(1):1-14 [17454399.001]
  • [Cites] Eur J Pharm Sci. 2007 Nov;32(3):159-68 [17707615.001]
  • [Cites] J Clin Oncol. 2000 Sep;18(17):3093-100 [10963637.001]
  • [Cites] Ann Oncol. 2000 Aug;11(8):1029-33 [11038041.001]
  • [Cites] Arch Dermatol. 2000 Dec;136(12):1475-80 [11115157.001]
  • [Cites] Biochim Biophys Acta. 2001 Apr 2;1511(2):397-411 [11286983.001]
  • [Cites] Gynecol Oncol. 2001 Sep;82(3):464-9 [11520141.001]
  • [Cites] Biochim Biophys Acta. 2001 Dec 1;1515(2):144-58 [11718670.001]
  • [Cites] Ann Oncol. 2002 Jun;13(6):910-8 [12123337.001]
  • [Cites] Biochim Biophys Acta. 2003 Jan 10;1609(1):102-8 [12507764.001]
  • [Cites] Cancer Res. 2003 Jan 1;63(1):86-92 [12517782.001]
  • [Cites] J Pharmacol Exp Ther. 2003 Sep;306(3):1058-67 [12808004.001]
  • [Cites] Biochim Biophys Acta. 2004 May 27;1663(1-2):167-77 [15157619.001]
  • [Cites] Expert Opin Ther Targets. 2004 Aug;8(4):335-53 [15268628.001]
  • [Cites] J Control Release. 2004 Nov 5;100(1):135-44 [15491817.001]
  • [Cites] FEBS Lett. 1990 Jul 30;268(1):235-7 [2384160.001]
  • [Cites] Biochim Biophys Acta. 1991 Jul 1;1066(1):29-36 [2065067.001]
  • [Cites] Biochim Biophys Acta. 1991 Sep 30;1068(2):133-41 [1911826.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11460-4 [1763060.001]
  • [Cites] J Clin Oncol. 1995 Jul;13(7):1777-85 [7602367.001]
  • [Cites] Immunol Lett. 1995 Jul-Aug;47(1-2):147-9 [8537094.001]
  • [Cites] BMJ. 1997 Aug 16;315(7105):422-5 [9277611.001]
  • [Cites] J Clin Oncol. 1997 Oct;15(10):3185-91 [9336354.001]
  • [Cites] Oncol Res. 1997;9(8):439-46 [9436197.001]
  • [Cites] Ann Oncol. 1998 Jul;9(7):711-6 [9739435.001]
  • [Cites] Nat Rev Drug Discov. 2005 Feb;4(2):145-60 [15688077.001]
  • [Cites] Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205 [15717745.001]
  • [Cites] Clin Cancer Res. 2005 May 1;11(9):3567-73 [15867261.001]
  • [Cites] Pharm Res. 2005 Jun;22(6):933-9 [15948037.001]
  • [Cites] J Drug Target. 2005 Jul;13(6):337-43 [16278153.001]
  • [Cites] Drug Discov Today. 2006 Sep;11(17-18):812-8 [16935749.001]
  • (PMID = 18329201.001).
  • [ISSN] 0378-5173
  • [Journal-full-title] International journal of pharmaceutics
  • [ISO-abbreviation] Int J Pharm
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL055519-12; United States / NHLBI NIH HHS / HL / R01 HL055519; United States / NHLBI NIH HHS / HL / R01 HL055519-12; United States / NHLBI NIH HHS / HL / R01 HL55519
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Antibodies, Monoclonal; 0 / Indium Radioisotopes; 0 / Liposomes; 0 / Pharmaceutical Vehicles; 30IQX730WE / Polyethylene Glycols; 80168379AG / Doxorubicin
  • [Other-IDs] NLM/ NIHMS51910; NLM/ PMC2680692
  •  go-up   go-down


7. Gómez-Caro A, Moradiellos FJ, Ausín P, Díaz-Hellín V, Larrú E, Pérez-Antón JA, Martín de Nicolás JL: [Risk factors for atrial fibrillation after thoracic surgery]. Arch Bronconeumol; 2006 Jan;42(1):9-13
MedlinePlus Health Information. consumer health - Atrial Fibrillation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Factores de riesgo en el desarrollo de fibrilación auricular tras cirugía torácica.
  • The following risk factors for atrial fibrillation were identified: age 70 years or older (P<.0004), prior heart disease (P<.005), patients undergoing operations for lung cancer (P<.04), and type of resection--right bilobectomy (P<.05) and left pneumonectomy (P<.03).
  • Hypertension, chronic obstructive pulmonary disease, and lung cancer stage were not risk factors.
  • CONCLUSIONS: After lung resection, atrial fibrillation is a common complication that seems to be associated with old age, history of heart disease, operations for lung cancer, left pneumectomy, and right bilobectomy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16426517.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


8. Wierzbicka M, Gawecki W, Leszczyńska M, Kopeć T: [Middle ear cancer hidden by chronic otitis media--a case report]. Otolaryngol Pol; 2008;62(6):797-9
MedlinePlus Health Information. consumer health - Ear Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Middle ear cancer hidden by chronic otitis media--a case report].
  • The authors would like to present a rare case of the middle ear cancer which has been developed in postoperative cave in 67 years old patient operated for cholesteatoma 50 years earlier.
  • The patient was admitted to the ENT Department of Poznań University of Medical Sciences because of the ear suppuration and headache occurring for 3 months.
  • The histopathology examination confirmed the final diagnosis of squamous cell cancer.
  • The authors report a case of middle ear squamous cell carcinoma and discuss its diagnostic aspect.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Ear Neoplasms / pathology. Ear Neoplasms / surgery. Ear, Middle. Otitis Media / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205537.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


9. Ragi JM, Patel D, Masud A, Rao BK: Nonmelanoma skin cancer of the ear: frequency, patients' knowledge, and photoprotection practices. Dermatol Surg; 2010 Aug;36(8):1232-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonmelanoma skin cancer of the ear: frequency, patients' knowledge, and photoprotection practices.
  • BACKGROUND: Nonmelanoma skin cancer (NMSC) is the most common cancer in the world.
  • Information about NMSC on the ear and photoprotection practices of the ear is limited.
  • OBJECTIVE: To determine the frequency of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) at precise anatomical sites, with a special focus on the ear.
  • To evaluate dermatology patients' knowledge about skin cancer, photoprotection practices, and use of photoprotection on the ear.
  • The ear was the fifth most common site for NMSC on the head.
  • The male:female ratio for NMSC of the ear was 17:1.
  • CONCLUSION: Directed public education about the ear as a high-risk, common site for NMSC is needed.
  • [MeSH-major] Carcinoma, Basal Cell / epidemiology. Carcinoma, Squamous Cell / epidemiology. Ear Neoplasms / epidemiology. Skin Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20666810.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Gurgel RK, Karnell LH, Hansen MR: Middle ear cancer: a population-based study. Laryngoscope; 2009 Oct;119(10):1913-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Middle ear cancer: a population-based study.
  • OBJECTIVES/HYPOTHESIS: Primary carcinoma of the middle ear is a rare clinical entity, best suited for evaluation using a population-based database.
  • The objective of this study was to utilize the Surveillance, Epidemiology, and End Results (SEER) database to determine the incidence, treatment, and survival of middle ear carcinoma.
  • STUDY DESIGN: Analysis of national cancer database.
  • METHOD: Using SEER*Stat software, records for patients diagnosed with middle ear carcinoma between 1973 and 2004 were extracted from the SEER database.
  • CONCLUSIONS: Patients with primary middle ear carcinoma have a relatively poor prognosis.
  • These data are useful in counseling patients and understanding the natural history of middle ear carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Ear Neoplasms / therapy. Ear, Middle. Temporal Bone / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19373882.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Duffy KL, McKenna JK, Hadley ML, Tristani-Firouzi P: Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size. Dermatol Surg; 2009 Jan;35(1):30-3
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
  • BACKGROUND: Nonmelanoma skin cancer (NMSC) of the ear can result in large defects with significant morbidity.
  • OBJECTIVE: To determine whether subanatomic location of NMSCs, based on ease of visualization of the ear, correlated with post-Mohs micrographic surgery (MMS) defect size.
  • METHODS: A retrospective chart review of 142 post-MMS ear lesions was performed and categorized according to subanatomic location: the helix, antihelix, and tragus (Location 1); retroauricular (Location 2); and conchal bowl, scapha, and triangular fossa (Location 3).
  • CONCLUSIONS: MMS defects of the ear are larger in nonvisible parts of the ear.
  • As a group, MMS defects on the ear were larger than those on the nose.
  • [MeSH-major] Ear Neoplasms / pathology. Ear Neoplasms / surgery. Mohs Surgery. Skin Neoplasms / pathology. Skin Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Basal Cell / pathology. Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Ear, External / anatomy & histology. Female. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19018813.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


12. Nguyen TH: Staged cheek-to-nose and auricular interpolation flaps. Dermatol Surg; 2005 Aug;31(8 Pt 2):1034-45
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Staged cheek-to-nose and auricular interpolation flaps.
  • BACKGROUND: Staged interpolation flaps are priceless options in skin cancer reconstruction.
  • Familiar interpolation flaps to dermatologic surgeons include the paramedian forehead flap, cheek-to-nose interpolation flaps, and auricular staged flaps.
  • This article highlights the cheek-to-nose and auricular interpolation flaps as applied to skin cancer defects.
  • RESULTS: With meticulous planning and thoughtful execution, cheek-to-nose and auricular staged flaps are capable of restoring both function and cosmesis.
  • CONCLUSION: Skin cancer patients with complex facial wounds from Mohs micrographic surgery may be assured of the highest possible cure rate.
  • Further, their esthetic and functional reconstructive goals may be achieved with staged flaps for the nose and ear.
  • [MeSH-minor] Cheek / surgery. Ear Cartilage / transplantation. Humans. Nose / surgery. Rhinoplasty / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16042927.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down


13. D'Arpa S, Cordova A, Moschella F: Further application of the bilobed flap: the split bilobed flap for reconstruction of composite posterior auricular and mastoid defects. J Plast Reconstr Aesthet Surg; 2006;59(12):1330-5
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Further application of the bilobed flap: the split bilobed flap for reconstruction of composite posterior auricular and mastoid defects.
  • In this article a modified bilobed flap from mastoid and lateral neck skin for reconstruction of complex defects of the posteromedial surface of the auricle and mastoid skin, with the preservation of the retroauricular sulcus, is described.
  • Reconstruction of the postero-medial auricular surface has almost never been a concern for reconstructive surgeons.
  • It is in fact a shaded area with little aesthetic relevance and direct closure, skin grafting and even secondary healing are used for skin cancer defects repair.
  • On the other hand, cancers involving the postero-medial auricular surface, the retroauricular sulcus and the mastoid skin require wide and deep resections that involve the posterior auricular muscles and reach the perichondral and periosteal surfaces.
  • Direct closure with undermining, if feasible, will obliterate the retroauricular sulcus causing asymmetry with the contralateral ear and, if defects are cephalad will impair the possibility of wearing spectacles, thus leaving functional and aesthetic impairment.
  • Two patients, both affected by basal cell carcinoma involving the posteromedial auricular surface and the mastoid skin have been treated with this flap.
  • [MeSH-major] Ear Deformities, Acquired / surgery. Ear, External / surgery. Reconstructive Surgical Procedures / methods. Scalp / surgery. Surgical Flaps
  • [MeSH-minor] Aged. Carcinoma, Basal Cell / surgery. Ear Neoplasms / surgery. Head and Neck Neoplasms / surgery. Humans. Male. Mastoid

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17113512.001).
  • [ISSN] 1748-6815
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


14. Crew KD, Capodice J, Greenlee H, Brafman L, Fuentes D, Awad D, Hershman DL: Randomized, blinded, placebo-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol; 2009 May 20;27(15_suppl):571

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Randomized, blinded, placebo-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
  • : 571 Background: Aromatase inhibitors (AIs) have become the standard of care for the treatment of postmenopausal, hormone-sensitive breast cancer (BC).
  • The active intervention included full body/auricular acupuncture and a joint-specific point prescription, whereas the sham arm involved superficial needle insertion at nonacupoint locations.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960742.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Bukrewicz M, Osmólski A, Fedorowicz M, Forlot J: [Cerebral abscess and ear cancer in the course of chronic otitis media]. Pol Merkur Lekarski; 2005 Sep;19(111):446-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cerebral abscess and ear cancer in the course of chronic otitis media].
  • Authors are discussing the coexistence of cerebral abscess and the ear cancer in the course of chronic otitis media.
  • They are emphasizing the existing danger of intracranial complications and at the same time the development of cancer with a non-typical course in the middle ear with effusion is more probable.
  • [MeSH-major] Brain Abscess. Carcinoma, Squamous Cell. Ear Neoplasms. Otitis Media with Effusion

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16358905.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


16. Seidler AM, Bramlette TB, Washington CV, Szeto H, Chen SC: Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness. Dermatol Surg; 2009 Nov;35(11):1776-87
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness.
  • PARTICIPANTS: Input data were derived from results of a consecutive sample of 98 patients with nonmelanoma skin cancer on the face and ears, estimates in the literature on 5-year recurrence rates, and a query of healthy focus-group participants.
  • CONCLUSIONS: Mohs may be more cost-effective than traditional excision in eradicating nonmelanoma skin cancer.
  • [MeSH-major] Ear Neoplasms / economics. Ear Neoplasms / surgery. Facial Neoplasms / economics. Facial Neoplasms / surgery. Mohs Surgery / economics. Skin Neoplasms / economics. Skin Neoplasms / surgery

  • Genetic Alliance. consumer health - Facial Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19737291.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Grant] United States / NIAMS NIH HHS / AR / K23AR02185-01A1; United States / NIAMS NIH HHS / AR / P30AR42687; United States / NIAMS NIH HHS / AR / T32 AR07587
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


17. Adriane K, Huang J, Ding G, Chen J, Liu Y: Self assembled magnetic PVP/PVA hydrogel microspheres; magnetic drug targeting of VX2 auricular tumours using pingyangmycin. J Drug Target; 2006 May;14(4):243-53
Hazardous Substances Data Bank. POLYVINYLPYRROLIDONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Self assembled magnetic PVP/PVA hydrogel microspheres; magnetic drug targeting of VX2 auricular tumours using pingyangmycin.
  • Chemotherapy in cancer treatment is associated with serious side effects and as a result there is great interest in research aimed at bringing down the level of systemic cytotoxicity.
  • In this study, we used self assembled PVP/PVA magnetic hydrogel microspheres to deliver pingyangmycin (Bleomycin A5) to rabbit auricular VX2 tumours in the presence of a 0.5 T permanent magnet both during and 24 h after perfusion.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Bleomycin / analogs & derivatives. Drug Delivery Systems. Ear Neoplasms / drug therapy. Hydrogel / administration & dosage. Magnetics. Microspheres

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. POLYVINYL ALCOHOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16777683.001).
  • [ISSN] 1061-186X
  • [Journal-full-title] Journal of drug targeting
  • [ISO-abbreviation] J Drug Target
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Drug Carriers; 11056-06-7 / Bleomycin; 11116-32-8 / bleomycetin; 25852-47-5 / Hydrogel; 9002-89-5 / Polyvinyl Alcohol; 9003-39-8 / Povidone
  •  go-up   go-down


18. Dessy LA, Figus A, Fioramonti P, Mazzocchi M, Scuderi N: Reconstruction of anterior auricular conchal defect after malignancy excision: revolving-door flap versus full-thickness skin graft. J Plast Reconstr Aesthet Surg; 2010 May;63(5):746-52
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reconstruction of anterior auricular conchal defect after malignancy excision: revolving-door flap versus full-thickness skin graft.
  • Skin tumours of the anterior auricular concha are not uncommon.
  • Wider excision and immediate reconstruction are required to reduce the risks of recurrence of the disease, cartilage infection and external ear distortion.
  • Post-auricular island flaps, such as the revolving-door (RD) flap, and full-thickness skin grafts (FTSGs) are the most-performed procedures.
  • Between March 2003 and January 2007, 40 patients affected by T1 and T2 non-melanotic skin cancer and T1 melanoma of the anterior conchal surface of the external ear were included in a prospective study and randomly assigned to the RD reconstructed group or to the FTSG reconstructed group to investigate, compare and define advantages and disadvantages of both the techniques.
  • The RD group demonstrated excellent cosmetic outcome, ideal colour match, adequate structure of external ear, projection and shape.
  • RD flap should be considered as the first choice for reconstruction of anterior auricular conchal defects following wider excision of skin tumours.
  • [MeSH-major] Ear Auricle. Ear Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Skin Neoplasms / surgery. Skin Transplantation / methods. Subcutaneous Tissue / transplantation. Surgical Flaps

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009. Published by Elsevier Ltd.
  • (PMID = 19357009.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] Netherlands
  •  go-up   go-down


19. Dib LL, de Oliveira JA, Neves RI, Sandoval RL, Nannmark U: Auricular rehabilitation by means of bone grafting from the iliac crest in combination with porous extraoral implants: a case report. Clin Implant Dent Relat Res; 2007 Dec;9(4):228-32
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Auricular rehabilitation by means of bone grafting from the iliac crest in combination with porous extraoral implants: a case report.
  • BACKGROUND: Maxillofacial defects caused by cancer treatment are a huge problem affecting the quality of life of patients.
  • MATERIALS AND METHODS: A new porous surfaced Brazilian extraoral implant (MasterExtra, Conexão, Sistema de Próteses, São Paulo, Brazil) was used.
  • A bone transplant from the iliac crest was taken to make it possible to insert at least three extraoral implants for an auricle epithesis.
  • Three fixtures were used for connection of an auricular epithesis.
  • [MeSH-major] Carcinoma, Basal Cell / rehabilitation. Ear, External / surgery. Head and Neck Neoplasms / rehabilitation. Prostheses and Implants. Prosthesis Implantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18031445.001).
  • [ISSN] 1523-0899
  • [Journal-full-title] Clinical implant dentistry and related research
  • [ISO-abbreviation] Clin Implant Dent Relat Res
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


20. Tanner PB, Mobley SR: External auricular and facial prosthetics: a collaborative effort of the reconstructive surgeon and anaplastologist. Facial Plast Surg Clin North Am; 2006 May;14(2):137-45, vi-vii
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] External auricular and facial prosthetics: a collaborative effort of the reconstructive surgeon and anaplastologist.
  • [MeSH-major] Ear, External / surgery. Face / surgery. Prostheses and Implants. Reconstructive Surgical Procedures / methods
  • [MeSH-minor] Cooperative Behavior. Ear Deformities, Acquired / surgery. Esthetics. Humans. Nose Deformities, Acquired / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16750771.001).
  • [ISSN] 1064-7406
  • [Journal-full-title] Facial plastic surgery clinics of North America
  • [ISO-abbreviation] Facial Plast Surg Clin North Am
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


21. Low WK, Burgess R, Fong KW, Wang DY: Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope; 2005 Oct;115(10):1823-6
MedlinePlus Health Information. consumer health - Radiation Therapy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: The cochlea may be damaged by modern conventional radiotherapy (RT) for head and neck cancers when the ear is included in the radiation field.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16222203.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL: Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol; 2010 Mar 1;28(7):1154-60
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
  • PURPOSE Women with breast cancer (BC) treated with aromatase inhibitors (AIs) may experience joint symptoms that can lead to discontinuation of effective therapy.
  • TA included full body/auricular acupuncture and joint-specific point prescriptions, whereas SA involved superficial needle insertion at nonacupoint locations.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Acupuncture.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20100963.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aromatase Inhibitors
  •  go-up   go-down


23. Zhang DK, Guo ZM, Zhang Q, Zeng ZY, Chen FJ, Chen WK, Li H, Wang SL: [Application of helix water jet to parotid surgery]. Ai Zheng; 2008 Jan;27(1):105-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 2004 to Feb. 2005 at Cancer Center of Sun Yat-Sen University, were analyzed.
  • Nine patients who retained nervus auricularis magnus suffered from slight numbness symptom of auricular lobule.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18184476.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


24. Takagi S, Inenaga R, Oya R, Nakamura S, Ikemura K: Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx. Br J Cancer; 2006 Jun 5;94(11):1580-5
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the i.a. group, carboplatin was infused into the lingual artery, and in the intravenous (i.v.) group, carboplatin was infused through the auricular vein.
  • Increased BVD was associated with a higher free platinum concentration in the tumour region in the i.a. group of rabbits.
  • Therefore, BVD is a valid predictor of the effects of i.a. targeted carboplatin chemotherapy and concurrent radiotherapy for treating human oral and oropharyngeal squamous cell carcinomas.

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2001 Aug 15;92(4):903-8 [11550164.001]
  • [Cites] Eur J Cancer. 1996 Dec;32A(14):2474-84 [9059336.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Jan;33(1):2-7 [14690652.001]
  • [Cites] Laryngoscope. 2004 Mar;114(3):411-7 [15091211.001]
  • [Cites] Br J Cancer. 2004 Jun 1;90(11):2062-6 [15150563.001]
  • [Cites] Cancer Res. 1986 Sep;46(9):4491-5 [3731104.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2047-50 [3771322.001]
  • [Cites] Science. 1987 Jan 23;235(4787):442-7 [2432664.001]
  • [Cites] Scand J Dent Res. 1987 Jun;95(3):229-49 [3299675.001]
  • [Cites] Lancet. 1987 Jun 20;1(8547):1398-402 [2884496.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):545-53 [10974475.001]
  • [Cites] J Clin Oncol. 1989 Nov;7(11):1748-56 [2681557.001]
  • [Cites] Cancer Res. 1989 Dec 1;49(23):6449-65 [2684393.001]
  • [Cites] Cancer. 1990 Apr 1;65(7):1619-25 [2311071.001]
  • [Cites] Radiother Oncol. 1991;20 Suppl 1:35-40 [2020767.001]
  • [Cites] Lancet. 1992 Jul 18;340(8812):145-6 [1378165.001]
  • [Cites] Lancet. 1992 Nov 7;340(8828):1120-4 [1279332.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1993 Jun;119(6):612-7 [8499090.001]
  • [Cites] Am J Surg. 1997 Nov;174(5):561-4 [9374238.001]
  • [Cites] Laryngoscope. 2002 Oct;112(10):1742-9 [12368607.001]
  • (PMID = 16670721.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] BG3F62OND5 / Carboplatin
  • [Other-IDs] NLM/ PMC2361327
  •  go-up   go-down


25. Lehnerdt G, Schmitz KJ, Dost P, Koch DA, Jahnke K: [Histological criteria and metastasis of squamous cell carcinoma of the pinna]. Laryngorhinootologie; 2005 Jul;84(7):482-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Histologische Kriterien und Metastasierungshäufigkeit von Plattenepithelkarzinomen der Ohrmuschel.
  • INTRODUCTION: According to the guidelines for cancer of the skin in the head and neck region of the German association of Otolaryngology, Head and Neck surgery squamous cell carcinoma (SCC) of the pinna are classified by using the current TNM system of skin cancer.
  • 36 % of SCC cases had infiltration of the auricular cartilage.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Ear Neoplasms / pathology. Ear, External / pathology. Lymphatic Metastasis / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16010628.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


26. Jinbo M, Ueda K, Kaneda Y, Sudo M, Li TS, Hamano K: Video-assisted transcatheter lung perfusion regional chemotherapy. Eur J Cardiothorac Surg; 2005 Jun;27(6):1079-82
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Under fluoroscopic and thoracoscopic guidance, five canine left lungs were isolated by means of an endovascular technique comprising pulmonary artery cannulation through the right femoral vein and pulmonary vein cannulation through the left auricular appendage (VATS-ILP).
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Chemotherapy, Cancer, Regional Perfusion. Cisplatin / administration & dosage. Lung. Lung Neoplasms / drug therapy. Thoracic Surgery, Video-Assisted

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15896621.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers; EC 1.1.1.27 / L-Lactate Dehydrogenase; EC 3.4.15.1 / Peptidyl-Dipeptidase A; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


27. Chistiakov AL, Klochikhin AL, Al-Kharbi AA: [Reconstructive surgical treatment of nasal skin cancer]. Vestn Otorinolaringol; 2010;(1):52-5
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Reconstructive surgical treatment of nasal skin cancer].
  • The postoperative defect was substituted by the following varieties of grafts: sliding cellulocutaneous flap (n=38), rotation cellulocutaneous buccal flap (n=36), free full-thickness flap (n=2), free chondrocutaneous flap (n=5), cutaneous-aponeurotic forehead flap (n=2), composite graft (cellulocutaneous buccal flap with a fragment of free auricular cartilage) (n=13).

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20436425.001).
  • [ISSN] 0042-4668
  • [Journal-full-title] Vestnik otorinolaringologii
  • [ISO-abbreviation] Vestn. Otorinolaringol.
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


28. Crew KD, Capodice JL, Greenlee H, Apollo A, Jacobson JS, Raptis G, Blozie K, Sierra A, Hershman DL: Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. J Cancer Surviv; 2007 Dec;1(4):283-91
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
  • INTRODUCTION: Aromatase inhibitors (AIs) have become the standard of care for the adjuvant treatment of postmenopausal, hormone-sensitive breast cancer.
  • METHODS: Postmenopausal women with early-stage breast cancer who had self-reported musculoskeletal pain related to adjuvant AI therapy were randomized in a crossover study to receive acupuncture twice weekly for 6 weeks followed by observation or vice-versa.
  • The intervention included full body and auricular acupuncture, and a joint-specific point prescription.
  • Outcome measures included the Brief Pain Inventory-Short Form (BPI-SF), Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index, the Functional Assessment of Cancer Therapy-General (FACT-G) quality of life measure, and serum levels of inflammatory markers, IL-1 beta and TNF-alpha.
  • IMPLICATIONS FOR CANCER SURVIVORS: Musculoskeletal side effects are common among breast cancer survivors on adjuvant AI therapy, therefore, effective treatments are needed for symptom relief and to improve adherence to these life-saving medications.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Joint Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2000 Nov 15;18(22):3748-57 [11078487.001]
  • [Cites] Arthritis Rheum. 1993 Sep;36(9):1305-14 [8216424.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):353-7 [11380221.001]
  • [Cites] BMJ. 2001 Sep 1;323(7311):467-8 [11532826.001]
  • [Cites] J Health Soc Policy. 2003;16(4):75-84 [12943333.001]
  • [Cites] Lancet. 2002 Jun 22;359(9324):2131-9 [12090977.001]
  • [Cites] Pain. 1999 Nov;83(2):157-62 [10534586.001]
  • [Cites] Clin Exp Immunol. 1989 Feb;75(2):306-10 [2784740.001]
  • [Cites] J Clin Oncol. 1997 Mar;15(3):974-86 [9060536.001]
  • [Cites] Oncol Nurs Forum. 2002 Nov-Dec;29(10):1445-52 [12432415.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):472-80 [12957259.001]
  • [Cites] Ann Acad Med Singapore. 1994 Mar;23(2):129-38 [8080219.001]
  • [Cites] Cancer. 2002 Feb 15;94(4):1151-6 [11920486.001]
  • [Cites] Brain Behav Immun. 2002 Dec;16(6):813-6 [12480510.001]
  • [Cites] J Clin Oncol. 2003 Nov 15;21(22):4120-6 [14615440.001]
  • [Cites] Arthritis Rheum. 1993 Jul;36(7):1007-13 [8318028.001]
  • [Cites] Nature. 1986 Aug 7-13;322(6079):547-9 [3736671.001]
  • [Cites] Arthritis Rheum. 1990 Apr;33(4):525-32 [2328031.001]
  • [Cites] Ann Intern Med. 2006 Jul 4;145(1):12-20 [16818924.001]
  • [Cites] Cancer. 2003 Nov 1;98(9):1802-10 [14584060.001]
  • [Cites] Am J Med. 2001 Apr 15;110(6):481-5 [11331060.001]
  • [Cites] Eur J Pain. 2005 Aug;9(4):437-44 [15979024.001]
  • [Cites] J Pharmacol Sci. 2006;100(5):443-59 [16799260.001]
  • [Cites] J Altern Complement Med. 2007 Jan-Feb;13(1):39-46 [17309376.001]
  • [Cites] Arthritis Rheum. 2001 Apr;44(4):819-25 [11315921.001]
  • [Cites] J Clin Oncol. 2004 Feb 15;22(4):671-7 [14966090.001]
  • [Cites] Arthritis Care Res. 1994 Sep;7(3):118-22 [7727550.001]
  • [Cites] J Clin Oncol. 2007 Sep 1;25(25):3877-83 [17761973.001]
  • [Cites] Am J Chin Med. 2007;35(1):21-5 [17265547.001]
  • [Cites] N Engl J Med. 1996 Jan 4;334(1):1-6 [7494563.001]
  • [Cites] Integr Cancer Ther. 2006 Mar;5(1):56-62 [16484714.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 1982;22:193-220 [7044284.001]
  • [Cites] J Pain Symptom Manage. 2003 Aug;26(2):731-42 [12906958.001]
  • [Cites] Obstet Gynecol. 1996 Feb;87(2 Suppl):20S-26S [8559550.001]
  • [Cites] J Altern Complement Med. 2002 Feb;8(1):85-9 [11890439.001]
  • [Cites] Arch Intern Med. 1996 Oct 14;156(18):2073-80 [8862099.001]
  • [Cites] J Clin Oncol. 2001 May 15;19(10):2767 [11352973.001]
  • [Cites] J Rheumatol. 1988 Dec;15(12):1833-40 [3068365.001]
  • [Cites] J Pain Symptom Manage. 2007 Oct;34(4):380-92 [17583467.001]
  • [Cites] CMAJ. 2007 Jan 16;176(2):179-83 [17224599.001]
  • [Cites] Ann Rheum Dis. 1997 Jul;56(7):432-4 [9486006.001]
  • [Cites] Support Care Cancer. 2006 Feb;14(2):172-6 [16021478.001]
  • [Cites] Med Hypotheses. 1995 Sep;45(3):271-81 [8569551.001]
  • [Cites] Arthritis Rheum. 2004 Jun;50(6):1967-75 [15188374.001]
  • [Cites] Acta Anaesthesiol Scand. 1992 Aug;36(6):519-25 [1514335.001]
  • [Cites] Acta Physiol Scand. 1977 Jul;100(3):382-4 [920207.001]
  • [Cites] Semin Oncol Nurs. 2005 Aug;21(3):190-5 [16092807.001]
  • [Cites] N Engl J Med. 2003 Nov 6;349(19):1793-802 [14551341.001]
  • [Cites] Forsch Komplementarmed Klass Naturheilkd. 2003 Aug;10(4):185-91 [12972723.001]
  • [Cites] N Engl J Med. 1992 Aug 27;327(9):620-7 [1640955.001]
  • [Cites] Life Sci. 1976 Dec 1;19(11):1757-62 [187888.001]
  • [Cites] N Engl J Med. 2004 Mar 11;350(11):1081-92 [15014181.001]
  • (PMID = 18648963.001).
  • [ISSN] 1932-2267
  • [Journal-full-title] Journal of cancer survivorship : research and practice
  • [ISO-abbreviation] J Cancer Surviv
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aromatase Inhibitors
  •  go-up   go-down


29. Matthews A, Dowswell T, Haas DM, Doyle M, O'Mathúna DP: Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev; 2010 Sep 08;(9):CD007575
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Evidence regarding the effectiveness of P6 acupressure, auricular (ear) acupressure and acustimulation of the P6 point was limited.

  • Genetic Alliance. consumer health - Nausea.
  • Genetic Alliance. consumer health - Pregnancy.
  • Genetic Alliance. consumer health - Vomiting.
  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • MedlinePlus Health Information. consumer health - Nausea and Vomiting.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Fam Physician. 2003 Jul 1;68(1):143-4 [12887120.001]
  • [Cites] Complement Ther Nurs Midwifery. 2003 Nov;9(4):176-81 [14556766.001]
  • [Cites] J Perinatol. 2003 Oct;23(7):531-5 [14566347.001]
  • [Cites] Cochrane Database Syst Rev. 2003;(4):CD000145 [14583914.001]
  • [Cites] J Med Assoc Thai. 2003 Sep;86(9):846-53 [14649969.001]
  • [Cites] J Obstet Gynaecol. 2004 Jan;24(1):28-32 [14675977.001]
  • [Cites] Aust N Z J Obstet Gynaecol. 2003 Apr;43(2):139-44 [14712970.001]
  • [Cites] Complement Ther Nurs Midwifery. 2004 Feb;10(1):30-6 [14744504.001]
  • [Cites] Obstet Gynecol. 2004 Apr;103(4):639-45 [15051552.001]
  • [Cites] Paediatr Perinat Epidemiol. 2004 Jul;18(4):253-9 [15255878.001]
  • [Cites] J R Coll Gen Pract. 1971 Aug;21(109):500-3 [4937061.001]
  • [Cites] J Reprod Med. 1971 Jul;7(1):35-7 [4948652.001]
  • [Cites] Br J Obstet Gynaecol. 1977 Jun;84(6):444-7 [329860.001]
  • [Cites] Minerva Ginecol. 1982 Jul-Aug;34(7-8):619-23 [7121892.001]
  • [Cites] Cancer Nurs. 1984 Feb;7(1):33-41 [6559094.001]
  • [Cites] CMAJ. 1985 Oct 15;133(8):755-8, 761 [4042058.001]
  • [Cites] J R Soc Med. 1988 Aug;81(8):456-7 [3418660.001]
  • [Cites] J Nurse Midwifery. 1989 Jul-Aug;34(4):171-8 [2769441.001]
  • [Cites] Br J Obstet Gynaecol. 1989 Nov;96(11):1304-11 [2611169.001]
  • [Cites] Obstet Gynecol. 1991 Jul;78(1):33-6 [2047064.001]
  • [Cites] Birth. 1992 Sep;19(3):138-43 [1388440.001]
  • [Cites] Obstet Gynecol. 1992 Nov;80(5):852-4 [1407927.001]
  • [Cites] J Reprod Med. 1993 Aug;38(8):603-6 [8410865.001]
  • [Cites] Am Fam Physician. 1993 Nov 15;48(7):1279-84 [8237742.001]
  • [Cites] Obstet Gynecol. 1994 Aug;84(2):245-8 [8041539.001]
  • [Cites] Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):881-4 [7573262.001]
  • [Cites] Reprod Toxicol. 1995 Jan-Feb;9(1):1-6 [8520127.001]
  • [Cites] Am J Obstet Gynecol. 1996 Feb;174(2):708-15 [8623811.001]
  • [Cites] Clin Nurs Res. 1997 Aug;6(3):239-52 [9281928.001]
  • [Cites] Obstet Gynecol. 1998 Jan;91(1):149-55 [9464741.001]
  • [Cites] Health Care Women Int. 1999 Jan-Feb;20(1):49-61 [10335155.001]
  • [Cites] Birth. 1999 Jun;26(2):108-14 [10687575.001]
  • [Cites] Am J Obstet Gynecol. 2000 Apr;182(4):931-7 [10764476.001]
  • [Cites] Br J Anaesth. 2000 Mar;84(3):367-71 [10793599.001]
  • [Cites] West J Surg Obstet Gynecol. 1951 May;59(5):216-34 [14836580.001]
  • [Cites] Br Med J. 1953 Mar 21;1(4811):652-3 [13032435.001]
  • [Cites] N Z Med J. 1955 Apr;54(300):215-8 [14384015.001]
  • [Cites] Obstet Gynecol. 1955 Sep;6(3):332-8 [13254040.001]
  • [Cites] Obstet Gynecol. 1958 Feb;11(2):214-9 [13504659.001]
  • [Cites] Lancet. 1962 Aug 25;2(7252):370-2 [13886359.001]
  • [Cites] Obstet Gynecol. 1961 Dec;18:753-6 [14007615.001]
  • [Cites] Med J Aust. 1964 Feb 15;1:234-6 [14116305.001]
  • [Cites] Pa Med J. 1964 Feb;67:37-40 [14125507.001]
  • [Cites] Obstet Gynecol. 1959 Nov;14:688-90 [13827111.001]
  • [Cites] J Midwifery Womens Health. 2005 Jan-Feb;50(1):e1-3 [15637501.001]
  • [Cites] J Perinat Neonatal Nurs. 2004 Oct-Dec;18(4):312-28 [15646303.001]
  • [Cites] J Obstet Gynaecol. 2005 Apr;25(3):241-4 [16147725.001]
  • [Cites] J Obstet Gynaecol. 2005 Aug;25(6):544-9 [16234137.001]
  • [Cites] Am J Obstet Gynecol. 2006 Mar;194(3):815-20 [16522418.001]
  • [Cites] Paediatr Perinat Epidemiol. 2006 Jul;20(4):270-8 [16879499.001]
  • [Cites] Aust Fam Physician. 2006 Sep;35(9):695 [16969438.001]
  • [Cites] Curr Med Res Opin. 2007 Apr;23(4):833-40 [17407640.001]
  • [Cites] J Med Assoc Thai. 2007 Jan;90(1):15-20 [17621727.001]
  • [Cites] Arch Gynecol Obstet. 2007 Sep;276(3):245-9 [17318558.001]
  • [Cites] J Obstet Gynaecol. 2007 May;27(4):360-2 [17654185.001]
  • [Cites] J Midwifery Womens Health. 2007 Sep-Oct;52(5):473-8 [17826710.001]
  • [Cites] J Med Assoc Thai. 2007 Sep;90(9):1703-9 [17957907.001]
  • [Cites] Am J Obstet Gynecol. 2008 Jan;198(1):71.e1-7 [18166311.001]
  • [Cites] Complement Ther Clin Pract. 2008 Feb;14(1):46-52 [18243942.001]
  • [Cites] Midwifery. 2008 Jun;24(2):143-52 [17316935.001]
  • [Cites] Int J Nurs Stud. 2008 Aug;45(8):1185-91 [17905253.001]
  • [Cites] J Med Assoc Thai. 2008 Nov;91(11):1633-8 [19127781.001]
  • [Cites] J Altern Complement Med. 2009 Mar;15(3):243-6 [19250006.001]
  • [Cites] Midwifery. 2009 Dec;25(6):649-53 [18272271.001]
  • [Cites] Drugs. 2000 Apr;59(4):781-800 [10804035.001]
  • [Cites] Am J Perinatol. 2000;17(4):207-18 [11041443.001]
  • [Cites] Obstet Gynecol. 2001 Feb;97(2):184-8 [11165579.001]
  • [Cites] J Obstet Gynecol Neonatal Nurs. 2001 Jan-Feb;30(1):61-70 [11277163.001]
  • [Cites] Obstet Gynecol. 2001 Apr;97(4):577-82 [11275030.001]
  • [Cites] Scand J Prim Health Care. 2001 Mar;19(1):43-7 [11303547.001]
  • [Cites] Clin Invest Med. 2001 Apr;24(2):90-3 [11368151.001]
  • [Cites] Nurs Res. 2001 Jul-Aug;50(4):251-7 [11480534.001]
  • [Cites] J Reprod Med. 2001 Sep;46(9):835-9 [11584487.001]
  • [Cites] Tidsskr Nor Laegeforen. 2001 Sep 30;121(23):2712-5 [11699379.001]
  • [Cites] Birth. 2002 Mar;29(1):1-9 [11843784.001]
  • [Cites] BJOG. 2002 Mar;109(3):227-35 [11950176.001]
  • [Cites] Midwifery. 2000 Sep;16(3):224-8 [10970756.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S182-3 [12011883.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S184-9 [12011884.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S198-203 [12011886.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S210-4 [12011888.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S220-7 [12011890.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S228-31 [12011891.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S232-8 [12011892.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S248-52 [12011895.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S253-5 [12011896.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S256-61 [12011897.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S262-6 [12011898.001]
  • [Cites] Wien Med Wochenschr. 2002;152(7-8):190-2 [12017746.001]
  • [Cites] Altern Ther Health Med. 2002 Sep-Oct;8(5):89-91 [12233808.001]
  • [Cites] Complement Ther Nurs Midwifery. 2002 Nov;8(4):191-6 [12463608.001]
  • [Cites] Complement Ther Med. 2002 Jun;10(2):78-83 [12481955.001]
  • [Cites] J Obstet Gynaecol. 2002 Sep;22(5):481-5 [12521412.001]
  • [Cites] Complement Ther Med. 2002 Dec;10(4):210-6 [12594971.001]
  • [Cites] Obstet Gynecol. 2003 Jul;102(1):129-35 [12850618.001]
  • [Cites] J Nurs Scholarsh. 2003;35(2):119-25 [12854291.001]
  • [Cites] Am Fam Physician. 2003 Jul 1;68(1):121-8 [12887118.001]
  • [UpdateIn] Cochrane Database Syst Rev. 2014;3:CD007575 [24659261.001]
  • (PMID = 20824863.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Grant] United Kingdom / Department of Health / / SRP/10/4001/02
  • [Publication-type] Journal Article; Meta-Analysis; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antiemetics; 12001-76-2 / Vitamin B Complex; 8059-24-3 / Vitamin B 6
  • [Number-of-references] 119
  • [Other-IDs] NLM/ EMS58085; NLM/ PMC4004939
  •  go-up   go-down


30. Kohno E, Murase S, Matsuyama K, Okamura N: Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits. Int J Med Sci; 2009;6(5):218-23
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Each test solution was infused into the auricular veins of rabbits.

  • MedlinePlus Health Information. consumer health - Steroids.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gan To Kagaku Ryoho. 2002 Apr;29(4):633-5 [11977554.001]
  • [Cites] Jpn J Clin Oncol. 2004 Apr;34(4):206-9 [15121757.001]
  • [Cites] J Surg Res. 1968 Nov;8(11):539-43 [5687385.001]
  • [Cites] Pharm Weekbl Sci. 1984 Apr 27;6(2):88-90 [6728639.001]
  • [Cites] Oncol Nurs Forum. 1990 May-Jun;17(3):387-9 [2342972.001]
  • [Cites] Nutrition. 1994 May-Jun;10(3):261-3 [7919680.001]
  • [Cites] Gan To Kagaku Ryoho. 2009 Jan;36(1):93-6 [19151570.001]
  • [Cites] J Toxicol Sci. 1998 Feb;23(1):77-85 [9513923.001]
  • [Cites] Nutrition. 1998 Jun;14(6):496-501 [9646289.001]
  • [Cites] J Appl Toxicol. 2004 Nov-Dec;24(6):409-13 [15558643.001]
  • [Cites] J Oncol Pharm Pract. 2005 Jun;11(2):79-81 [16460608.001]
  • [Cites] Lung Cancer. 2007 Mar;55(3):337-41 [17126951.001]
  • [Cites] Int J Med Sci. 2008;5(4):218-23 [18695742.001]
  • [Cites] J Chemother. 1997 Aug;9(4):304-8 [9269613.001]
  • (PMID = 19680474.001).
  • [ISSN] 1449-1907
  • [Journal-full-title] International journal of medical sciences
  • [ISO-abbreviation] Int J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Antineoplastic Agents; 5V9KLZ54CY / Vinblastine; 7S5I7G3JQL / Dexamethasone; 80168379AG / Doxorubicin; 9PHQ9Y1OLM / Prednisolone; Q6C979R91Y / vinorelbine
  • [Other-IDs] NLM/ PMC2726577
  • [Keywords] NOTNLM ; anthracyclines / antineoplastic agents / corticosteroid / doxorubicin / phlebitis / rabbit ear vein / vinca alkaloids / vinorelbine
  •  go-up   go-down


31. Jeblaoui Y, Neji B, Haddad S, Mnif D, Hchicha S: [Difficulties of the management of head and neck neurofibromatosis]. Ann Chir Plast Esthet; 2007 Feb;52(1):43-50
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Difficultés de la prise en charge des atteintes de l'extrémité céphalique dans les neurofibromatoses.
  • However, all our patients were satisfied with the result and we noted recurrence in a patient presenting a retro-auricular tumor, which filled the external auditory canal requiring a further surgery.
  • Cancer risks and the disease's completely unpredictable evolution urge a regular and multidisciplinary patient follow-up.

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17137698.001).
  • [ISSN] 0294-1260
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


32. Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D: The Australian Mohs database: short-term recipient-site complications in full-thickness skin grafts. Dermatol Surg; 2006 Nov;32(11):1364-8
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: This study is based on a prospective data collection of all patients in Australia treated with MMS and monitored by the Skin and Cancer Foundation, between 1993 and 2002.
  • Most tumors were basal call carcinoma (90.9%) and were located on the nose (63.8%), periocular area (14.8%), or auricular area (8.1%).
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Australia / epidemiology. Carcinoma, Basal Cell / epidemiology. Carcinoma, Basal Cell / etiology. Carcinoma, Basal Cell / pathology. Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Databases, Factual. Ear, External. Female. Forehead. Graft Survival. Humans. Male. Middle Aged. Mohs Surgery / statistics & numerical data. Nose. Postoperative Complications. Prospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17083589.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R: Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol; 2005 Sep;53(3):445-51
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: This prospective, multicenter case series included all patients in Australia treated with MMS for BCC, who were monitored by the Skin and Cancer Foundation between 1993 and 2002.
  • Most of the tumors (98.3%) were on the head and neck area, most commonly on the nose (39%), cheek and maxilla (16.5%), periocular area (12.7%), and auricular region (11.4%).

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16112351.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


34. Chen J, Niu YH, Li GL, Wang GF, Zhao MH: [Clinical feature analysis of 190 patients with anti-neutrophil cytoplasmic antibodies associated vasculitis]. Zhonghua Yi Xue Za Zhi; 2009 Sep 29;89(36):2548-51
MedlinePlus Health Information. consumer health - Vasculitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 156 cases aged 40 - 80 years old (82.1%) and 162 patients (85.3%) were of primary AAV including 146 cases of P-ANCA positive and 16 cases of C-ANCA positive.
  • There were 28 patients with secondary AAV including 18 cases of connective tissue disease, 7 cases of propylthiouracil induction, 1 case each of idiopathic thrombocytopenic purpura, lung cancer and endometrial carcinoma.
  • There were 25 cases of P-ANCA positive and 3 cases of C-ANCA positive in secondary AAV.
  • Oral and auricular involvement was more in P-ANCA group than in C-ANCA group.

  • Genetic Alliance. consumer health - Vasculitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20137616.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibodies, Antineutrophil Cytoplasmic
  •  go-up   go-down


35. Zhang B, Huang HZ, Pan CB, Wang JG, Chen WL, Yang ZH: [Effect analysis of modified radical surgery in tongue cancer at early stages]. Zhonghua Yi Xue Za Zhi; 2007 Sep 25;87(36):2578-80
Genetic Alliance. consumer health - Tongue cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect analysis of modified radical surgery in tongue cancer at early stages].
  • OBJECTIVE: To evaluate the oncologic efficacy, surgical safety, postoperative beauty, and morbidity of an ideal procedure of modified radical surgery in tongue cancer at early stages.
  • METHODS: Six patients with early stage squamous cell carcinoma of tongue underwent a procedure of modified radical surgery, in which an inconspicuous incision was used, the external jugular vein, sternocleidomastoid muscle, spino-accessory nerve, and greater auricular nerve were preserved, half of glosso and mouth floor were excised, and the defect was repaired instantly.
  • Recurrence of glosso, mouth floor and neck, regional edema, shoulder dysfunction, auricle sensibility, oral cavity function and beautiful outlook on the face and neck were evaluated clinically.
  • RESULTS: Compared with classic radical neck dissection, this procedure of modified radical surgery showed an inconspicuous incision and pretty appearance, minor edema on face and neck, better shoulder function, and sensation of auricular skin.
  • CONCLUSION: This ideal procedure of modified radical surgery in tongue cancer at early stages lessens or avoids destruction of face and neck, shoulder malfunction, numbness of auricular skin, and oral dysfunction of speech, swallow and mastication without impairment on the oncologic safety of the radical surgery, and improves the quality of life of the patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18067839.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


36. Peng H, Peng HD, Xu L, Lao LX: [Efficacy of acupuncture in treatment of cancer pain: a systematic review]. Zhong Xi Yi Jie He Xue Bao; 2010 Jun;8(6):501-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Efficacy of acupuncture in treatment of cancer pain: a systematic review].
  • BACKGROUND: Although acupuncture is a well-established treatment for cancer pain and its effects have been widely reported in recent two decades, there is still controversy over whether its efficacy is better than placebo.
  • OBJECTIVE: To evaluate the efficacy of acupuncture therapy on cancer pain.
  • The high-quality trial showed that auricular acupuncture therapy was significantly superior to placebo in pain alleviation.

  • MedlinePlus Health Information. consumer health - Acupuncture.
  • MedlinePlus Health Information. consumer health - Pain.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20550871.001).
  • [ISSN] 1672-1977
  • [Journal-full-title] Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
  • [ISO-abbreviation] Zhong Xi Yi Jie He Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] China
  •  go-up   go-down


37. Roy S, Dhingra KK, Gupta P, Khurana N, Gupta B, Meher R: Acinic cell carcinoma with extensive neuroendocrine differentiation: a diagnostic challenge. Head Neck Pathol; 2009 Jun;3(2):163-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 48 year old lady presented with a gradually increasing right infra-auricular swelling for a period of 1 year which enlarged suddenly in a short period.

  • Genetic Alliance. consumer health - Acinic Cell Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathobiology. 1990;58(4):212-20 [1701303.001]
  • [Cites] Ear Nose Throat J. 2006 Aug;85(8):533-9 [16999063.001]
  • [Cites] APMIS. 2006 Oct;114(10):720-5 [17004975.001]
  • [Cites] Pancreas. 2009 Mar;38(2):219-22 [19238022.001]
  • [Cites] Mod Pathol. 2000 May;13(5):554-61 [10824928.001]
  • [Cites] Acta Pathol Jpn. 1990 Apr;40(4):279-87 [2371833.001]
  • [Cites] Am J Otolaryngol. 2004 Mar-Apr;25(2):129-33 [14976661.001]
  • [Cites] J Laryngol Otol. 1979 Apr;93(4):325-40 [438614.001]
  • [Cites] J Clin Pathol. 1982 Jun;35(6):611-6 [7085912.001]
  • [Cites] Cancer. 1987 Sep 1;60(5):962-8 [3300954.001]
  • [Cites] Cancer. 1987 Oct 1;60(7):1583-8 [2441846.001]
  • [Cites] Anticancer Res. 2001 May-Jun;21(3C):2131-4 [11501836.001]
  • (PMID = 19644544.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acinic cell / Carcinoma / Chromogranin / Neuroendocrine / Parotid / Warthin’s
  •  go-up   go-down


38. Milunsky JM, Maher TA, Zhao G, Roberts AE, Stalker HJ, Zori RT, Burch MN, Clemens M, Mulliken JB, Smith R, Lin AE: TFAP2A mutations result in branchio-oculo-facial syndrome. Am J Hum Genet; 2008 May;82(5):1171-7
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The major features include cutaneous anomalies (cervical, infra- and/or supra-auricular defects, often with dermal thymus), ocular anomalies, characteristic facial appearance (malformed pinnae, oral clefts), and, less commonly, renal and ectodermal (dental and hair) anomalies.
  • Four additional BOFS patients were found to have de novo missense mutations in the highly conserved exons 4 and 5 (basic region of the DNA binding domain) of the TFAP2A gene in the candidate deleted region.


39. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M: VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood; 2007 Nov 1;110(9):3158-67
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Long-lasting inflammation induced a significant increase in the number of lymphatic endothelial cells, not only in the inflamed ears but also in the ear-draining auricular LNs.

  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 2001 Mar;96(3):822-8 [11280558.001]
  • [Cites] Blood. 2007 Feb 1;109(3):1010-7 [17032920.001]
  • [Cites] J Exp Med. 2001 Nov 5;194(9):1361-73 [11696600.001]
  • [Cites] Nat Med. 2003 Jun;9(6):669-76 [12778165.001]
  • [Cites] Blood. 2003 Jul 1;102(1):161-8 [12649136.001]
  • [Cites] Curr Opin Cell Biol. 2003 Oct;15(5):515-24 [14519385.001]
  • [Cites] FASEB J. 2004 Jan;18(1):218-20 [14597566.001]
  • [Cites] J Am Soc Nephrol. 2004 Mar;15(3):603-12 [14978162.001]
  • [Cites] J Clin Invest. 2004 Apr;113(7):1040-50 [15057311.001]
  • [Cites] Dermatol Online J. 1999 May;5(1):7 [10673450.001]
  • [Cites] J Exp Med. 2000 Nov 20;192(10):1425-40 [11085745.001]
  • [Cites] J Investig Dermatol Symp Proc. 2000 Dec;5(1):14-9 [11147669.001]
  • [Cites] Nat Med. 2001 Feb;7(2):192-8 [11175850.001]
  • [Cites] Nat Med. 2004 Aug;10(8):813-5 [15235599.001]
  • [Cites] Blood. 2004 Aug 15;104(4):1048-57 [15100155.001]
  • [Cites] J Immunol. 1994 Apr 15;152(8):4149-56 [7511670.001]
  • [Cites] Mol Biol Cell. 1993 Dec;4(12):1317-26 [8167412.001]
  • [Cites] J Exp Med. 1994 Sep 1;180(3):1141-6 [8064230.001]
  • [Cites] J Immunol. 1995 Mar 15;154(6):2801-7 [7876550.001]
  • [Cites] J Invest Dermatol. 1995 May;104(5):744-9 [7738351.001]
  • [Cites] J Invest Dermatol. 1998 Jul;111(1):1-6 [9665379.001]
  • [Cites] Am J Pathol. 1998 Aug;153(2):587-98 [9708818.001]
  • [Cites] J Pathol. 1998 Oct;186(2):186-91 [9924435.001]
  • [Cites] Am J Pathol. 1999 Feb;154(2):385-94 [10027397.001]
  • [Cites] J Clin Invest. 2005 Feb;115(2):247-57 [15668734.001]
  • [Cites] J Exp Med. 2005 Apr 4;201(7):1089-99 [15809353.001]
  • [Cites] Nat Rev Cancer. 2005 Sep;5(9):735-43 [16079909.001]
  • [Cites] Annu Rev Cell Dev Biol. 2005;21:457-83 [16212503.001]
  • [Cites] Nature. 2005 Dec 15;438(7070):946-53 [16355212.001]
  • [Cites] J Biol Chem. 2006 Jan 13;281(2):951-61 [16278208.001]
  • [Cites] Nat Med. 2006 Feb;12(2):230-4 [16415878.001]
  • [Cites] Immunity. 2006 Feb;24(2):129-31 [16473825.001]
  • [Cites] Immunity. 2006 Feb;24(2):203-15 [16473832.001]
  • [Cites] Nat Immunol. 2006 May;7(5):507-16 [16617337.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11405-10 [16849433.001]
  • [Cites] J Immunol. 2006 Sep 1;177(5):3369-79 [16920978.001]
  • [Cites] J Leukoc Biol. 2006 Oct;80(4):691-6 [16793912.001]
  • [Cites] Am J Pathol. 2001 Sep;159(3):893-903 [11549582.001]
  • (PMID = 17625067.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA092644; United States / NCI NIH HHS / CA / R01 CA069184; United States / NCI NIH HHS / CA / CA 69184; United States / NCI NIH HHS / CA / CA 92644
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vascular Endothelial Growth Factor A; 0 / vascular endothelial growth factor A, mouse
  • [Other-IDs] NLM/ PMC2200913
  •  go-up   go-down


40. Rapini RP, Warner NB: Relapsing polychondritis. Clin Dermatol; 2006 Nov-Dec;24(6):482-5
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Auricular chondritis, with red ears resembling infectious cellulitis, is the most common initial finding.
  • Chronic disease may result in a flabby, droopy ear, cauliflower ear, or saddle nose deformity.

  • Genetic Alliance. consumer health - Relapsing polychondritis.
  • MedlinePlus Health Information. consumer health - Steroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17113965.001).
  • [ISSN] 0738-081X
  • [Journal-full-title] Clinics in dermatology
  • [ISO-abbreviation] Clin. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Antimetabolites; 0 / Glucocorticoids; 0 / Immunosuppressive Agents; VB0R961HZT / Prednisone
  • [Number-of-references] 35
  •  go-up   go-down


41. Wei CC, Sanfilippo NJ, Myssiorek D: Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum. Curr Oncol; 2010 Jun;17(3):83-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE PRESENTATION: A xeroderma pigmentosum patient presented to our clinic with a 2-cm right submental and 1-cm right infra-auricular mass after resection of multiple squamous cell carcinomas of the scalp and face, and external-beam radiation therapy to the right face and neck.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cutan Med Surg. 1998 Jan;2(3):153-8 [9479081.001]
  • [Cites] Radiother Oncol. 2000 Nov;57(2):143-54 [11054518.001]
  • [Cites] Anticancer Drugs. 2006 Feb;17(2):133-8 [16428930.001]
  • [Cites] Adv Exp Med Biol. 2008;637:19-27 [19181107.001]
  • [Cites] Radiother Oncol. 2006 Oct;81(1):1-8 [16971009.001]
  • [Cites] Eur J Dermatol. 2009 Mar-Apr;19(2):163-5 [19106040.001]
  • [Cites] Br J Radiol. 2006 Jun;79(942):510-7 [16714754.001]
  • (PMID = 20567629.001).
  • [ISSN] 1718-7729
  • [Journal-full-title] Current oncology (Toronto, Ont.)
  • [ISO-abbreviation] Curr Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Other-IDs] NLM/ PMC2880910
  • [Keywords] NOTNLM ; Xeroderma pigmentosum / head-and-neck cancer / radiation / re-irradiation
  •  go-up   go-down


42. Barbosa LA, Teixeira CR: Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. Am J Health Syst Pharm; 2008 Jun 1;65(11):1048-50
Hazardous Substances Data Bank. PHENYTOIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After 2 days, the patient returned to the hospital with severe mucositis and an erythematous macular eruption on the scalp and auricular region within the radiation field.

  • Genetic Alliance. consumer health - Erythema Multiforme.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18499877.001).
  • [ISSN] 1535-2900
  • [Journal-full-title] American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • [ISO-abbreviation] Am J Health Syst Pharm
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticonvulsants; 6158TKW0C5 / Phenytoin
  •  go-up   go-down


43. Mansky PJ, Wallerstedt DB: Complementary medicine in palliative care and cancer symptom management. Cancer J; 2006 Sep-Oct;12(5):425-31
MedlinePlus Health Information. consumer health - Palliative Care.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complementary medicine in palliative care and cancer symptom management.
  • Complementary and alternative medicine (CAM) use among cancer patients varies according to geographical area, gender, and disease diagnosis.
  • The prevalence of CAM use among cancer patients in the United States has been estimated to be between 7% and 54%.
  • Most cancer patients use CAM with the hope of boosting the immune system, relieving pain, and controlling side effects related to disease or treatment.
  • This review article focuses on practices belonging to the CAM domains of mind-body medicine, CAM botanicals, manipulative practices, and energy medicine, because they are widely used as complementary approaches to palliative cancer care and cancer symptom management.
  • In the area of cancer symptom management, auricular acupuncture, therapeutic touch, and hypnosis may help to manage cancer pain.
  • Music therapy, massage, and hypnosis may have an effect on anxiety, and both acupuncture and massage may have a therapeutic role in cancer fatigue.
  • Most CAM approaches to the treatment of cancer are safe when used by a CAM practitioner experienced in the treatment of cancer patients.
  • Botanicals should be used with caution by cancer patients and only under the guidance of an oncologist knowledgeable in their use.


44. Stucker FJ, Walsh WE, Dammert M, Lian T: The perichondrial cutaneous graft: a facial reconstructive option for the ages (ages 1 week to 94 years). Laryngoscope; 2008 Oct;118(10):1753-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The donor site is closed by resecting a fenestra of conchal cartilage and rotating a posterior auricular interpolated island flap into the defect (the "flip-flop-flap").
  • The posterior auricular defect is easily closed in a linear fashion.
  • There were 170 grafts used for trauma and 236 used for reconstruction after skin cancer resection.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18622316.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. Burdick JA, Chung C, Jia X, Randolph MA, Langer R: Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules; 2005 Jan-Feb;6(1):386-91
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Finally, auricular swine chondrocytes produced neocartilage when photoencapsulated in the hyaluronic acid networks.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1984 Jun;(186):231-9 [6723151.001]
  • [Cites] Ann Biomed Eng. 2004 Mar;32(3):391-7 [15095813.001]
  • [Cites] J Biomed Mater Res A. 2004 Jul 1;70(1):74-82 [15174111.001]
  • [Cites] Anal Biochem. 1988 Oct;174(1):168-76 [2464289.001]
  • [Cites] J Biomed Mater Res. 1993 Sep;27(9):1129-34 [8126011.001]
  • [Cites] J Biomed Mater Res. 1994 Aug;28(8):891-9 [7983087.001]
  • [Cites] J Biomed Mater Res. 1995 Sep;29(9):1147-54 [8567713.001]
  • [Cites] Plast Reconstr Surg. 1995 Nov;96(6):1390-8; discussion 1399-400 [7480239.001]
  • [Cites] J Cell Biochem. 1996 Jun 15;61(4):569-77 [8806080.001]
  • [Cites] Ann Plast Surg. 1998 Apr;40(4):413-20; discussion 420-1 [9555998.001]
  • [Cites] Plast Reconstr Surg. 1998 May;101(6):1580-5 [9583489.001]
  • [Cites] J Control Release. 1998 Apr 30;53(1-3):93-103 [9741917.001]
  • [Cites] Cancer Lett. 1998 Sep 11;131(1):3-11 [9839614.001]
  • [Cites] Biomaterials. 1998 Dec;19(23):2101-27 [9884052.001]
  • [Cites] Wound Repair Regen. 1999 Mar-Apr;7(2):79-89 [10231509.001]
  • [Cites] Anal Biochem. 1962 Oct;4:330-4 [13971270.001]
  • [Cites] Plast Reconstr Surg. 1999 Sep;104(4):1014-22 [10654741.001]
  • [Cites] Biomaterials. 2000 Apr;21(8):795-801 [10721748.001]
  • [Cites] J Biomed Mater Res. 2000 Aug;51(2):164-71 [10825215.001]
  • [Cites] J Biomater Sci Polym Ed. 2000;11(5):439-57 [10896041.001]
  • [Cites] J Biomed Mater Res. 2001 Jan;54(1):115-21 [11077410.001]
  • [Cites] J Orthop Res. 2000 Sep;18(5):773-80 [11117300.001]
  • [Cites] Biomaterials. 2001 Mar;22(6):619-26 [11219727.001]
  • [Cites] Biomaterials. 2002 Nov;23(22):4315-23 [12219821.001]
  • [Cites] J Biomed Mater Res A. 2003 Jan 1;64(1):70-9 [12483698.001]
  • [Cites] Biomaterials. 2003 Mar;24(6):893-900 [12504509.001]
  • [Cites] Histochem J. 1969 Feb;1(3):199-204 [4113282.001]
  • (PMID = 15638543.001).
  • [ISSN] 1525-7797
  • [Journal-full-title] Biomacromolecules
  • [ISO-abbreviation] Biomacromolecules
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / K22 DE015761-01; United States / NIDCR NIH HHS / DE / R01 DE013023; United States / NIDCR NIH HHS / DE / DE015761-01; United States / NIDCR NIH HHS / DE / K22 DE015761; United States / NIDCR NIH HHS / DE / 5R01 DE-13023-05; United States / NIDCR NIH HHS / DE / K22 DE-015761-01
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anhydrides; 0 / Hydrogels; 0 / Polymers; 9004-61-9 / Hyaluronic Acid
  • [Other-IDs] NLM/ NIHMS103719; NLM/ PMC2678566
  •  go-up   go-down


46. Hashikawa K, Terashi H, Tahara S: Therapeutic strategy for the triad of acquired anophthalmic orbit. Plast Reconstr Surg; 2007 Jun;119(7):2182-8; discussion 2189-91
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 1992, the authors developed a therapeutic strategy based on a simple algorithm for treating the three common symptoms of acquired anophthalmic orbit: severe eye socket contracture is surgically treated with a radial forearm free flap transfer, upper lid depression is treated with lipoinjection, and lower lid retraction is treated with an auricular cartilage graft.
  • RESULTS: Sixteen patients underwent auricular cartilage grafts, eight received radial forearm free flap transfers, and seven were treated with lipoinjection.
  • The aesthetic outcome was assessed as good in six patients, moderate in eight patients, and poor in four patients; the last four had undergone total maxillectomy with orbital exenteration or had eyelid defects because of previous cancer surgery.

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17519719.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Civelek AC, Patel P, Ozalp E, Brem RF: Tc-99m sestamibi uptake in the chest mimicking a malignant lesion of the breast. Breast; 2006 Feb;15(1):111-4
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The use of nuclear medicine imaging of the breast has resulted in the improved diagnosis of breast cancer (Radiology 196 (1995) 421; J. Nucl. Med.
  • This report describes a previously unrecognized cause for a false positive interpretation of scintimammography due to tumor uptake of the radiotracer in the chest as a result of physiologic activity in the auricular aspect of the right atrium.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16473742.001).
  • [ISSN] 0960-9776
  • [Journal-full-title] Breast (Edinburgh, Scotland)
  • [ISO-abbreviation] Breast
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


48. Lausch E, Hermanns P, Farin HF, Alanay Y, Unger S, Nikkel S, Steinwender C, Scherer G, Spranger J, Zabel B, Kispert A, Superti-Furga A: TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndrome. Am J Hum Genet; 2008 Nov;83(5):649-55
SciCrunch. KEGG: Data: Disease Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We identified two unrelated individuals with a complex cranial, cervical, auricular, and skeletal malformation syndrome with scapular and pelvic hypoplasia (Cousin syndrome) that recapitulates the dysmorphic phenotype seen in the Tbx15-deficient mice, droopy ear.
  • We conclude that Cousin syndrome is caused by TBX15 insufficiency and is thus the human counterpart of the droopy ear mouse.


49. Ling R, Li Y, Yao Q, Chen T, Zhu D, Jun Y, Chen J: Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model. J Drug Target; 2005 Feb;13(2):137-42
Hazardous Substances Data Bank. DOXORUBICIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of the study was to evaluate the potential of lymphatic chemotherapy in inducing apoptosis in axillary lymph node metastases in a rabbit breast cancer model.
  • Group B received free adriamycin (FADR) administered into the auricular vein.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15823965.001).
  • [ISSN] 1061-186X
  • [Journal-full-title] Journal of drug targeting
  • [ISO-abbreviation] J Drug Target
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Liposomes; 80168379AG / Doxorubicin
  •  go-up   go-down


50. Zanation AM, Ebert CS Jr, Coffey CS, Dubin MG, Rose AS: Precursor B-cell lymphoblastic lymphoma presenting as an isolated external ear swelling in a two-year-old child. Int J Pediatr Otorhinolaryngol; 2005 May;69(5):695-9
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Precursor B-cell lymphoblastic lymphoma presenting as an isolated external ear swelling in a two-year-old child.
  • The incidence of lymphoma in children is increasing in the United States and is the third most common childhood cancer.
  • We present and discuss the diagnosis and management of the first report of a child with an auricular mass as the sole manifestation of B-cell non-Hodgkin's lymphoma.
  • [MeSH-major] Ear Neoplasms / diagnosis. Ear, External / pathology. Lymphoma, B-Cell / diagnosis

  • Genetic Alliance. consumer health - Lymphoblastic lymphoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DAUNORUBICIN .
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15850691.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; VB0R961HZT / Prednisone; ZS7284E0ZP / Daunorubicin
  •  go-up   go-down


51. Rossi E, Franchella A: Amputation neuroma following a circumcision: a case report. Eur J Pediatr Surg; 2006 Aug;16(4):288-90
MedlinePlus Health Information. consumer health - Circumcision.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are also few reported cases localised at the orbit, on the great auricular nerve [2], and in the neck after radical neck dissection for oral cancer [5, 7].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16981099.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


52. Yumoto E, Sanuki T, Kumai Y: Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope; 2006 Sep;116(9):1657-61
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The objective of this prospective study was to assess the long-term effects of immediate reconstruction of the recurrent laryngeal nerve (RLN) during thyroid cancer extirpation on postoperative phonatory function.
  • SUBJECTS AND METHODS: The subjects were 22 patients with advanced thyroid cancer who underwent resection of the primary lesion and involved RLN.
  • Immediate reconstruction of the RLN was performed on eight patients using the great auricular nerve and one underwent direct anastomosis of the RLN stumps (group I).
  • The remaining four had arytenoid adduction immediately after cancer extirpation (group III).
  • CONCLUSION: Immediate RLN reconstruction at the time of thyroid cancer extirpation can provide excellent postoperative phonatory function.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16954999.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


53. Yun HR, Yoo HS, Shin DY, Hong SH, Kim JH, Cho CK, Choi YH: Apoptosis induction of human lung carcinoma cells by Chan Su (Venenum Bufonis) through activation of caspases. J Acupunct Meridian Stud; 2009 Sep;2(3):210-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chan Su is a traditional Chinese medicine prepared from the dried white secretion of the auricular and skin glands of toads, and has been used as an oriental drug for the treatment of a number of diseases, including cancer.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20633494.001).
  • [ISSN] 2093-8152
  • [Journal-full-title] Journal of acupuncture and meridian studies
  • [ISO-abbreviation] J Acupunct Meridian Stud
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Bufanolides; 0 / chan su; EC 3.4.22.- / Caspases
  •  go-up   go-down


54. Kohno E, Murase S, Nishikata M, Okamura N, Matzno S, Kuwahara T, Matsuyama K: Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits. Int J Med Sci; 2008;5(4):218-23
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • VNR was diluted with normal saline to prepare test solutions with concentrations of 0.6 mg/mL or 0.3 mg/mL for infusion into the auricular veins of rabbits.
  • [MeSH-minor] Animals. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Agents, Phytogenic / adverse effects. Disease Models, Animal. Ear / blood supply. Fat Emulsions, Intravenous / pharmacology. Infusions, Intravenous. Male. Rabbits. Severity of Illness Index. Sodium Chloride / pharmacology

  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. SODIUM CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Jpn J Clin Oncol. 2005 Jun;35(6):310-5 [15930037.001]
  • [Cites] Nutrition. 1998 Jun;14(6):496-501 [9646289.001]
  • [Cites] Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9 [16937106.001]
  • [Cites] Lung Cancer. 2007 Mar;55(3):337-41 [17126951.001]
  • [Cites] Gan To Kagaku Ryoho. 2007 Aug;34(8):1255-7 [17687207.001]
  • [Cites] Oncologist. 2001;6 Suppl 1:4-7 [11181997.001]
  • [Cites] Support Care Cancer. 2001 Mar;9(2):108-11 [11305068.001]
  • [Cites] J Clin Oncol. 2001 Jul 1;19(13):3210-8 [11432888.001]
  • [Cites] Cancer. 2001 Nov 1;92(9):2267-72 [11745280.001]
  • [Cites] Gan To Kagaku Ryoho. 2002 Apr;29(4):633-5 [11977554.001]
  • [Cites] J Natl Cancer Inst. 2003 Mar 5;95(5):362-72 [12618501.001]
  • [Cites] J Surg Res. 1968 Nov;8(11):539-43 [5687385.001]
  • [Cites] NITA. 1984 Nov-Dec;7(6):478-82 [6568460.001]
  • [Cites] Acta Anaesthesiol Scand Suppl. 1985;82:33-7 [3904298.001]
  • [Cites] Oncol Nurs Forum. 1995 May;22(4):707-10 [7675673.001]
  • [Cites] Surg Today. 1995;25(8):667-71 [8520158.001]
  • [Cites] J Chemother. 1997 Aug;9(4):304-8 [9269613.001]
  • [Cites] J Toxicol Sci. 1998 Feb;23(1):77-85 [9513923.001]
  • [Cites] Nutrition. 1998 Feb;14(2):186-90 [9530646.001]
  • [Cites] J Oncol Pharm Pract. 2005 Jun;11(2):79-81 [16460608.001]
  • (PMID = 18695742.001).
  • [ISSN] 1449-1907
  • [Journal-full-title] International journal of medical sciences
  • [ISO-abbreviation] Int J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Fat Emulsions, Intravenous; 451W47IQ8X / Sodium Chloride; 5V9KLZ54CY / Vinblastine; Q6C979R91Y / vinorelbine
  • [Other-IDs] NLM/ PMC2500147
  • [Keywords] NOTNLM ; infusion rate / phlebitis / rabbit ear vein / solution concentration / vinorelbine
  •  go-up   go-down


55. Vankalakunti M, Das A, Rao NK: Postauricular congenital alveolar rhabdomyosarcoma- a case report of an unusual entity. Diagn Pathol; 2006;1:37

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE PRESENTATION: We report a case of congenital alveolar rhabdomyosarcoma in an 18-month-old male who presented with a progressively increasing mass lesion in the left post-auricular region since birth.
  • In the Medline literature search, there is no report of large congenital alveolar rhabdomyosarcoma in the post-auricle region.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 1973 Sep;178(3):346-51 [4729757.001]
  • [Cites] Cancer. 1986 Dec 15;58(12):2606-10 [3779610.001]
  • [Cites] Med Pediatr Oncol. 1994;22(5):309-17 [8127254.001]
  • [Cites] Cancer. 2001 Feb 1;91(3):606-12 [11169945.001]
  • [Cites] Fetal Diagn Ther. 2005 Jul-Aug;20(4):291-5 [15980643.001]
  • [Cites] Pediatr Pathol. 1990;10(4):509-26 [2164660.001]
  • [Cites] J Pediatr Surg. 1994 Aug;29(8):1167-70 [7965528.001]
  • [Cites] Med Pediatr Oncol. 1989;17(2):105-10 [2704331.001]
  • [Cites] Cancer. 1988 Jan 15;61(2):209-20 [3275486.001]
  • (PMID = 17044930.001).
  • [ISSN] 1746-1596
  • [Journal-full-title] Diagnostic pathology
  • [ISO-abbreviation] Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1621081
  •  go-up   go-down


56. Gentile P, Bottini DJ, Colicchia GM, Trimarco A, Cervelli V: Burns: bone-anchored, extra-oral implantology. J Burn Care Res; 2008 Jul-Aug;29(4):627-31
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two female patients were selected; they were treated from December 2001 to June 2007 by implanting auricular epithesis.
  • They shared the same diagnosis: burns of the auricle-temporal region.
  • The deformity in the auricle region and the complete absence of the pinna convinced the authors to choose this reconstructive method.
  • Most patients showed a good stability of fixtures, epithesis and perimplants soft tissue, in some cases there has been a delay in the time to healing soft tissue perimplant and only one patient has removed the plant after 5 years cancer recurrence.
  • [MeSH-major] Burns / surgery. Ear Auricle / surgery. Prostheses and Implants. Reconstructive Surgical Procedures / methods

  • MedlinePlus Health Information. consumer health - Burns.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18535470.001).
  • [ISSN] 1559-047X
  • [Journal-full-title] Journal of burn care & research : official publication of the American Burn Association
  • [ISO-abbreviation] J Burn Care Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Shan XF, Cai ZG, Zhang JG, Zhang J, Gao Y, Yu GY: Management of sialoblastoma with surgery and brachytherapy. Pediatr Blood Cancer; 2010 Dec 15;55(7):1427-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor was excised with negative margins, and the sacrificed facial nerve was reconstructed with great auricular nerve graft.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20734405.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. van Holten MJ, Roesink JM, Terhaard CH, Braam PM: New insights in the vascular supply of the human parotid gland - consequences for parotid gland-sparing irradiation. Head Neck; 2010 Jul;32(7):837-43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Xerostomia is caused by irradiation for head and neck cancer, depending on the dose to the parotid gland.
  • RESULTS: Five arterial vessels were responsible for the vascular supply of the parotid gland: the posterior auricular artery, 2 branches so far unnamed, the superficial temporal artery, and the transverse facial artery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley Periodicals, Inc.
  • (PMID = 19862825.001).
  • [ISSN] 1097-0347
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Ko WS, Park TY, Park C, Kim YH, Yoon HJ, Lee SY, Hong SH, Choi BT, Lee YT, Choi YH: Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells. Oncol Rep; 2005 Aug;14(2):475-80
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chan Su is a traditional Chinese medicine prepared from the dried white secretion of the auricular and skin glands of toads, and has been used as an Oriental drug.
  • However, little is known about the effect of Chan Su on the growth of human cancer cells.
  • Taken together, these findings partially provide novel insights into the possible molecular mechanisms of the anti-cancer activity of Chan Su.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012733.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Amphibian Venoms; 0 / BAX protein, human; 0 / BCL2L1 protein, human; 0 / Bufanolides; 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Membrane Proteins; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Trans-Activators; 0 / bcl-2-Associated X Protein; 0 / bcl-X Protein; 0 / beta Catenin; 0 / chan su; EC 1.14.99.1 / Cyclooxygenase 1; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / PTGS1 protein, human; EC 1.14.99.1 / PTGS2 protein, human; EC 1.14.99.1 / Prostaglandin-Endoperoxide Synthases; EC 2.4.2.30 / Poly(ADP-ribose) Polymerases; EC 3.4.22.- / CASP3 protein, human; EC 3.4.22.- / CASP9 protein, human; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspase 9; EC 3.4.22.- / Caspases; K7Q1JQR04M / Dinoprostone
  •  go-up   go-down






Advertisement